The Kaiser Daily Health Policy Report is published for Kaisernetwork.org, a free program of The Henry J. Kaiser Family Foundation. Copyright 2006 Advisory Board Firm and Kaiser Family Base. All rights reserved.. Cipla, Ranbaxy to trim pediatric antiretroviral drug prices Indian pharmaceutical companies Cipla and Ranbaxy in an agreement with the Clinton Base will reduce the prices of 19 different pediatric antiretroviral drugs in 62 developing countries to an average of 45 percent significantly less than what treatments currently cost in the countries, on Thursday before World AIDS Day time on Dec former President Clinton announced. 1, the AP/Forbes reports . Among the formulations, a new three-in-one treatment for children, will cost about 16 cents each day, or $60 annually, based on the foundation.In the statement from Sutter, officials stated the prices reflect the costs of complying with the state’s earthquake retrofit requirements, improving caring and technology for increasing numbers of patients who cannot pay. ‘Our contracts with medical health insurance programs are completely negotiated with these sophisticated companies,’ the declaration read. Modern Healthcare: Calif. Insurance Commissioner Joins Whistle-Blower Lawsuit Against Sutter Health Insurer The insurance commissioner of California has became a member of a whistle-blower lawsuit against Sutter Health and a managed-care company, alleging that they manipulate anesthesia billing codes and drive up overall healthcare costs fraudulently.